Physalin B TN2063
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Physalin B shows antimalarial, anti-Trypanosoma cruzi, anti-bacterial, anti- leukemia activities, it has the potential to be developed as an effective chemotherapeutic lead compound for the treatment of malignant melanoma, it inhibits androgen-independent
CAS nr:
23133-56-4
Purity:
98%
Molecular Weight:
510,53
SMILES:
C[C@]([C@@H](C[C@@]1(C)[C@@H]2C3=O)O4)([C@@]2([C@@]2(CC[C@@H]([C@H]5CC=C6CC=C7)[C@@]6(C)C7=O)O)O[C@]35OC[C@H]1C4=O)OC2=O
Formula:
C28H30O9
Pathway:
Microbiology/Virology,Apoptosis,Proteases/Proteasome,Apoptosis
Target:
Antifection,Caspase,Caspase,BCL
